Forbes January 21, 2025
Weight-loss drugs like Ozempic may offer health benefits far beyond those already flagged by research, a large-scale study suggests.
Scientists probing the health records of nearly 216,000 people with diabetes who took the GLP-1 receptor antagonists found they had a lower risk of 42 conditions than people on other forms of treatment. They also had a higher risk of 19 health problems.
Some results, like reduced risk of cardiovascular disease and increased chance of nausea and vomiting, were expected. But others, like a lower risk of bacterial infection and an increased chance of joint pain, took researchers by suprise.
Some surprising observations included an 18% percent lower risk of psychotic disorders like schizophrenia and a 12% lower chance of Alzheimer’s....
Today's Sponsors
Today's Sponsor